Showing results (161-170 of 307) with videos related to
Sort By:
Pageof 31
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2017
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's diseaseRobert A Hauser, William C Koller, Jean P Hubble, et al.The Lancet. Neurology|August 2, 2016
Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targetsAlberto J Espay, Peter A LeWitt, Robert A Hauser, et al.Clinical Neuropharmacology|November 11, 2006
Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson diseaseRobert A Hauser, Hermann Russ, Doris-Anita Haeger, et al.Clinical Neuropharmacology|May 28, 2009
Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson diseaseTheresa A Zesiewicz, Robert A Hauser, Alan Freeman, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 11, 2012
AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studiesRobert A Hauser, Daniel Truong, Jean Hubble, et al.European Neurology|January 30, 2009
Treatment of early Parkinson's disease. Part 1Tanya Simuni, Kelly E Lyons, Rajesh Pahwa, et al.European Neurology|January 30, 2009
Treatment of early Parkinson's disease. Part 2Tanya Simuni, Kelly E Lyons, Rajesh Pahwa, et al.Clinical Neuropharmacology|September 6, 2012
Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystoniaDavid Charles, Allison Brashear, Robert A Hauser, et al.Parkinson'S Disease|June 17, 2022
Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational SearchGareth Morinan, Robert A Hauser, Anette Schrag, et al.The Lancet. Neurology|February 15, 2011
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trialRobert A Hauser, Marc Cantillon, Emmanuelle Pourcher, et al.Pageof 31